Product Description: SARS-CoV-2 Mpro-IN-39 (Compound 9d) is an inhibitor of the main protease (Mpro) of SARS-CoV-2, with an IC50 value of 5.94 µM, an EC50 value of 9.33 µM for inhibiting the replication of SARS-CoV-2 in Vero cells, and a cytotoxicity CC50 value of 289.63 µM. SARS-CoV-2 Mpro-IN-39 can be used in the research of the anti-COVID-19 field[1].
Formula: C23H22N4O2S
References: [1]Farghaly TA, et al. Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease Inhibitors. Drug Dev Res. 2025 Apr;86(2):e70081.
Molecular Weight: 418.51
Research Area: Infection
Target: SARS-CoV;Virus Protease